| P50 | author | Mohammad Ishraq Zafar | Q58482963 |
| P2093 | author name string | Feng Gao | |
| | Bertram Wiedenmann | |
| | Stefan Jüttner | |
| | Michael Höcker | |
| P2860 | cites work | The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention | Q24601222 |
| | The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice | Q25255790 |
| | NSAIDs and chemoprevention | Q28167254 |
| | NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR)delta expression in APC(min/+) mice proportionally to their tumor inhibitory effect: Implications for the role of PPARdelta in carcinogenesis | Q28190606 |
| | Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors | Q28290833 |
| | Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs | Q28372797 |
| | Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) | Q28586461 |
| | Cyclooxygenases: structural, cellular, and molecular biology | Q29616510 |
| | Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma. | Q30858776 |
| | The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. | Q33737469 |
| | Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma | Q34021476 |
| | Molecular characteristics of eight gastric cancer cell lines established in Japan | Q34099128 |
| | Cancer-stromal cell interaction and tumor angiogenesis in gastric cancer | Q34268727 |
| | Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. | Q34571903 |
| | Cyclooxygenase isozymes and their gene structures and expression | Q34997933 |
| | The diffuse endocrine system: from embryogenesis to carcinogenesis. | Q35131420 |
| | Cyclooxygenase-2 polymorphisms and bladder cancer risk: a meta-analysis based on case-control studies | Q35643802 |
| | Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis. | Q35676053 |
| | The diagnosis and medical management of advanced neuroendocrine tumors. | Q35794419 |
| | Cyclooxygenase as a target in lung cancer | Q35817554 |
| | NO-Donating NSAIDs, PPARdelta, and Cancer: Does PPARdelta Contribute to Colon Carcinogenesis? | Q37182798 |
| | The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment | Q37366259 |
| | The desmoplastic stroma plays an essential role in the accumulation and modulation of infiltrated immune cells in pancreatic adenocarcinoma | Q39724884 |
| | Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors | Q39773838 |
| | Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines | Q41169636 |
| | Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion. | Q41500266 |
| | Regulation of Pancreastatin Release from a Human Pancreatic Carcinoid Cell Line in Vitro* | Q41699809 |
| | Characterisation of a cell line (LCC-18) from a cultured human neuroendocrine-differentiated colonic carcinoma | Q41705685 |
| | Pancreastatin producing cell line from human pancreatic islet cell tumor. | Q41736727 |
| | Gastroenteropancreatic neuroendocrine tumors: diagnosis and treatment | Q42406543 |
| | Establishment of a carcinoembryonic antigen-producing cell line from human pancreatic carcinoma | Q42801670 |
| | Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours | Q43446974 |
| | Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. | Q43611737 |
| | Immunohistochemical analysis of cyclooxygenase (COX)-2 expression in pancreatic endocrine tumors: association with tumor progression and proliferation | Q43907575 |
| | Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors. | Q50909020 |
| | Comparison of seven cell lines derived from human gastric carcinomas. | Q52832256 |
| | Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. | Q53413153 |
| | Shared tumor antigens in colorectal carcinoma and neuroendocrine tumors | Q74448888 |
| | Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma | Q74449907 |
| | Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice | Q77060828 |
| | Cyclooxygenase-2 expression correlates with phaeochromocytoma malignancy: evidence for a Bcl-2-dependent mechanism | Q81397073 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8125-8140 | |
| P577 | publication date | 2018-11-13 | |
| P1433 | published in | Medical Science Monitor | Q15756323 |
| P1476 | title | Expression and Molecular Regulation of the Cox2 Gene in Gastroenteropancreatic Neuroendocrine Tumors and Antiproliferation of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) | |
| P478 | volume | 24 | |